2 Oct 2026, 16:58
Securities Administration—
PHXPHARMX TECHNOLOGIES LIMITED
Announcement history available from 1 August 2025
Fromto
29 Sept 2026, 17:53
Securities Administration—
29 Sept 2026, 17:52
Securities Administration—
29 Sept 2026, 17:49
Securities Administration—
22 Sept 2026, 10:00
Presentations—
21 Sept 2026, 11:19
Meetings & Governance—
27 Aug 2026, 08:57
Financial ResultsMS
27 Aug 2026, 08:56
Financial ResultsMS
27 Aug 2026, 08:54
Company Administration—
27 Aug 2026, 08:53
Financial ResultsMS
20 Aug 2026, 10:36
Presentations—
10 July 2026, 16:01
Securities Administration—
10 July 2026, 15:56
Securities Administration—
10 July 2026, 15:52
Substantial Holders—
7 July 2026, 09:12
Company Update—
29 June 2026, 09:53
Company Update—
17 June 2026, 09:52
Presentations—
5 May 2026, 11:46
Periodic Reports—
13 Mar 2026, 11:52
Director Interests—
13 Mar 2026, 11:50
Company Administration—
12 Mar 2026, 10:59
Substantial Holders—
26 Feb 2026, 16:31
Securities Administration—
26 Feb 2026, 16:27
Securities Administration—
25 Feb 2026, 08:32
Financial ResultsMS
25 Feb 2026, 08:27
Financial ResultsMS
25 Feb 2026, 08:26
Financial ResultsMS
23 Feb 2026, 08:47
Securities Administration—
23 Feb 2026, 08:27
Company UpdateMS
4 Feb 2026, 09:13
Periodic Reports—
11 Nov 2025, 11:52
Meetings & Governance—
11 Nov 2025, 09:38
Presentations—
11 Nov 2025, 08:26
Company Administration—
10 Oct 2025, 09:43
Meetings & Governance—
7 Oct 2025, 16:23
Securities Administration—
7 Oct 2025, 16:17
Securities Administration—
7 Oct 2025, 16:15
Securities Administration—
7 Oct 2025, 16:13
Securities Administration—
25 Sept 2025, 09:25
Company Administration—
12 Sept 2025, 16:49
Meetings & Governance—
1 Sept 2025, 17:35
Director Interests—
1 Sept 2025, 17:35
Director Interests—
1 Sept 2025, 17:33
Director Interests—
1 Sept 2025, 17:32
Company Administration—
20 Aug 2025, 09:10
Financial ResultsMS
20 Aug 2025, 09:09
Financial ResultsMS
20 Aug 2025, 09:04
Company Administration—
20 Aug 2025, 09:04
Financial ResultsMS
13 Aug 2025, 09:23
Presentations—
| Date / Time | Heading | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 2 Oct 2026, 16:58 | Cleansing Notice | Securities Administration | — | 06018 | |
| 29 Sept 2026, 17:53 | Application for quotation of securities - PHX | Securities Administration | — | 06020 | |
| 29 Sept 2026, 17:52 | Notification regarding unquoted securities - PHX | Securities Administration | — | 06021 | |
| 29 Sept 2026, 17:49 | Notification of cessation of securities - PHX | Securities Administration | — | 06027 | |
| 22 Sept 2026, 10:00 | Pharmx to present at Coffee Microcaps Sydney Conference | Presentations | — | 03026 | |
| 21 Sept 2026, 11:19 | 2026 Annual General Meeting - Key Dates | Meetings & Governance | — | 08006 | |
| 27 Aug 2026, 08:57 | FY26 Results Presentation | Financial Results | MS | 03003, 03026 | |
| 27 Aug 2026, 08:56 | Announcement of FY26 Results | Financial Results | MS | 03003, 03014 | |
| 27 Aug 2026, 08:54 | Appendix 4G & FY26 Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 27 Aug 2026, 08:53 | Appendix 4E & FY26 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 20 Aug 2026, 10:36 | Notice of FY26 Results Announcement | Presentations | — | 03027, 14014 | |
| 10 July 2026, 16:01 | Cleansing Notice | Securities Administration | — | 06018 | |
| 10 July 2026, 15:56 | Application for quotation of securities - PHX | Securities Administration | — | 06020 | |
| 10 July 2026, 15:52 | Sigma Healthcare 10% strategic holding now complete | Substantial Holders | — | 02006 | |
| 7 July 2026, 09:12 | Pharmx Renews National NDSS Agreement | Company Update | — | 11001 | |
| 29 June 2026, 09:53 | Agreement of first work item under Sigma Strategic Alliance | Company Update | — | 11001 | |
| 17 June 2026, 09:52 | Notice of Investor Presentation | Presentations | — | 03026 | |
| 5 May 2026, 11:46 | Q3 Investor Update FY2026 | Periodic Reports | — | 03014 | |
| 13 Mar 2026, 11:52 | Initial Director's Interest Notice - M Conway | Director Interests | — | 02008 | |
| 13 Mar 2026, 11:50 | Director Appointment | Company Administration | — | 12001 | |
| 12 Mar 2026, 10:59 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 26 Feb 2026, 16:31 | Cleansing Notice | Securities Administration | — | 06018 | |
| 26 Feb 2026, 16:27 | Application for quotation of securities - PHX | Securities Administration | — | 06020 | |
| 25 Feb 2026, 08:32 | H1 FY26 Investor Presentation | Financial Results | MS | 03002, 03004, 03026 | |
| 25 Feb 2026, 08:27 | H1 FY26 Results Announcement | Financial Results | MS | 03004 | |
| 25 Feb 2026, 08:26 | Half Yearly Reports & Accounts | Financial Results | MS | 03004, 03009, 03010, 03015, 03019 | |
| 23 Feb 2026, 08:47 | Proposed issue of securities - PHX | Securities Administration | — | 06013 | |
| 23 Feb 2026, 08:27 | Pharmx and Sigma enter multi-year strategic alliance | Company Update | MS | 11001 | |
| 4 Feb 2026, 09:13 | Notice of Results Announcement - 31 December 2025 | Periodic Reports | — | 03027 | |
| 11 Nov 2025, 11:52 | Results of Annual General Meeting | Meetings & Governance | — | 08003 | |
| 11 Nov 2025, 09:38 | Chairman's Address & CEO Presentation | Presentations | — | 03026, 15002 | |
| 11 Nov 2025, 08:26 | Pharmx launches new Marketplace platform | Company Administration | — | 12008 | |
| 10 Oct 2025, 09:43 | Notice of Annual General Meeting & Proxy Form | Meetings & Governance | — | 08001, 08004, 16002 | |
| 7 Oct 2025, 16:23 | Update - Notification of cessation of securities - PHX | Securities Administration | — | 06027 | |
| 7 Oct 2025, 16:17 | Notification of cessation of securities - PHX | Securities Administration | — | 06027 | |
| 7 Oct 2025, 16:15 | Notification regarding unquoted securities - PHX | Securities Administration | — | 06021 | |
| 7 Oct 2025, 16:13 | Application for quotation of securities - PHX | Securities Administration | — | 06020 | |
| 25 Sept 2025, 09:25 | Update on Pharmacy Portal - StockView Feature Introduction | Company Administration | — | 12008 | |
| 12 Sept 2025, 16:49 | 2025 Annual General Meeting - Key Dates | Meetings & Governance | — | 08006, 12008 | |
| 1 Sept 2025, 17:35 | Initial Director's Interest Notice - A Mellis | Director Interests | — | 02008 | |
| 1 Sept 2025, 17:35 | Final Director's Interest Notice - A Mellis | Director Interests | — | 02010 | |
| 1 Sept 2025, 17:33 | Final Director's Interest Notice - D Bastas | Director Interests | — | 02010 | |
| 1 Sept 2025, 17:32 | Director Changes & Office Address Update | Company Administration | — | 12001, 12003 | |
| 20 Aug 2025, 09:10 | Investor Presentation | Financial Results | MS | 03003, 03026 | |
| 20 Aug 2025, 09:09 | FY25 Results | Financial Results | MS | 03003, 03014 | |
| 20 Aug 2025, 09:04 | Appendix 4G & Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 20 Aug 2025, 09:04 | Appendix 4E & FY2025 Annual Report | Financial Results | MS | 03001, 03002, 03003, 03011, 03012, 03013, 03020 | |
| 13 Aug 2025, 09:23 | Notice of Results Announcement | Presentations | — | 03027, 14014 |
1–48 of 48
1 / 1